Search research articles
Contact Us
Filters
Showing results (141-150 of 144) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 144 results.
The Journal of Dermatologic Surgery
|
November 1, 1976
M-plasty techniques
R C Webster, T M Davidson, R C Smith, et al.
Annals of Surgical Oncology
|
May 31, 2014
Full-thickness closure in breast-conserving surgery: the impact on radiotherapy target definition for boost and partial breast irradiation. A multimodality image evaluation
Mariska D den Hartogh, H J G Desirée van den Bongard, Melanie T M Davidson, et al.
Gynecologic Oncology
|
January 29, 2023
Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer
T M Davidson, C L Lebreton, A E Wahner Hendricksen, et al.
Gynecologic Oncology
|
October 13, 2021
Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer
G E Konecny, A E Wahner Hendrickson, T M Davidson, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 144) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 144 results.
The Journal of Dermatologic Surgery
|
November 1, 1976
M-plasty techniques
R C Webster, T M Davidson, R C Smith, et al.
Annals of Surgical Oncology
|
May 31, 2014
Full-thickness closure in breast-conserving surgery: the impact on radiotherapy target definition for boost and partial breast irradiation. A multimodality image evaluation
Mariska D den Hartogh, H J G Desirée van den Bongard, Melanie T M Davidson, et al.
Gynecologic Oncology
|
January 29, 2023
Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer
T M Davidson, C L Lebreton, A E Wahner Hendricksen, et al.
Gynecologic Oncology
|
October 13, 2021
Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer
G E Konecny, A E Wahner Hendrickson, T M Davidson, et al.
Page
of 15